Trial intelligence / Profile preview

Aspirin and Rosuvastatin for Atherosclerosis Prevention in SLE

NCT00371501Phase 4Completed

Sponsor
Tuen Mun Hospital
Start
Jun 2006
Primary completion
Dec 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin, aspirin in atherosclerosis, thromboembolism, sponsored by Tuen Mun Hospital. Started Jun 2006; status: completed.

02

Drugs

rosuvastatinaspirin
03

Conditions

atherosclerosisthromboembolism

Beyond the preview

Go deeper on NCT00371501.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00371501.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call